Adverse Events Risk Associated With Regorafenib in the Treatment of Advanced Solid Tumors: Meta-Analysis of Randomized Controlled Trials
OncoTargets and Therapy - New Zealand
doi 10.2147/ott.s156760
Full Text
Open PDFAbstract
Available in full text
Date
October 1, 2018
Authors
Publisher
Informa UK Limited